Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer treatment reports

• Publication date

  1987-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 3308081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report

  1987cited by this paper
• Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors.

  1984cited by this paper
• Combination chemotherapy with MOPP in children with recurrent brain tumors.

  1978cited by this paper
• Hodgkin's disease in childhood.

  1973cited by this paper

• Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity

  2014cites this paper
• Corticosteroid-related psychiatric complications in the treatment of Hodgkin's lymphoma in an adolescent.

  2007cites this paper
• Chemotherapy for high-grade gliomas of childhood

  1999cites this paper
• Chemotherapy for intracranial ependymomas

  1999cites this paper
• Phase I Therapy Trials in Children With Cancer

  1998cites this paper
• Chemotherapy of Childhood Posterior Fossa Tumors

  1993cites this paper
• Non-enzymatic activation of procarbazine to active cytotoxic species.

  1992cites this paper
• Isolation, purification, and characterization of two new chemical decomposition products of methylazoxyprocarbazine.

  1992cites this paper
• Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma

  1992cites this paper
• Chemotherapy of malignant brain tumors in children.

  1992cites this paper
• [Chemotherapy of brain tumors in children].

  1990cites this paper
• [Systemic chemotherapy with conventional doses for brain tumors in children: phase II trials].

  1990cites this paper
• Methylazoxyprocarbazine, the active metabolite responsible for the anticancer activity of procarbazine against L1210 leukemia.

  1989cites this paper